Global Leukapheresis Device Market Revenue and CAGR Forecast Analysis 2025–2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Leukapheresis Device Market?
In recent times, the leukapheresis device market has displayed substantial expansion. The market, which was valued at $0.65 billion in 2024, is set to grow to $0.70 billion in 2025, marking a compound annual growth rate (CAGR) of 7.7%. Factors contributing to the growth observed in the historic period include an increasing demand for tailored medical solutions, a heightened emphasis on research and development, a surge in clinical trials activity, an expanding aging demographic, and a growing preference for minimally invasive procedures.
In the coming years, the leukapheresis device market is poised to experience robust growth, with projections indicating a market value of $0.94 billion by 2029. This accounts for a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this growth for the projected period include the increasing frequency of blood-related disorders, growth in cancer cases, the escalating need for peripheral blood stem cell collection, more prevalent usage of leukapheresis in cellular therapies, and enhanced investments in regenerative medicine and immunotherapy. The forecast period is expected to witness several trends, including advancements in apheresis devices, the incorporation of automation and digital interfaces, progression in point-of-care leukapheresis technology, development of closed-loop leukapheresis systems, and improvements in cell separation efficiency driven by technology.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp
What Core Drivers Are Expected To Influence The Leukapheresis Device Market?
Anticipated to be fueled by the growing occurrence of blood-related diseases, the leukapheresis device market’s expansion is on the rise. Blood-related health issues, which affect the blood cells’ structure or functionality, result in challenges with oxygen delivery, immune reaction, or blood coagulation. The surge in these health issues is mainly linked to the elderly demographic, who are more prone to conditions such as anemia, leukemia, and a variety of hematological disorders. Leukapheresis devices, by selective extraction of excessive or abnormal white blood cells from the bloodstream, aid in treating these diseases, alleviating symptoms and decreasing complications in diseases like leukemia and autoimmune conditions. As per the Leukaemia Foundation, a non-profit organization based in Australia, in May 2024, about 19,403 Australians were diagnosed with blood cancers like leukemia, lymphoma, or myeloma in 2022, averaging 53 cases daily or one every 27 minutes. Nowadays nearly 135,000 Australians are living with a blood cancer or blood disorder, a figure estimated to surpass 275,000 by 2035. Hence, the escalating prevalence of blood-related diseases is propelling the growth of the leukapheresis device market.
Which Segmentation Categories Are Highlighted In The Leukapheresis Device Market Analysis?
The leukapheresis device market covered in this report is segmented –
1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices
2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters
3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers
Subsegments:
1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices
2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems
3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems
4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices
5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators
6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags
7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems
Which Market Trends Are Expected To Define The Future Of The Leukapheresis Device Market?
The key players in the leukapheresis device sector are strategically investing in localized production capabilities to bolster access to superior therapeutic devices and contribute to the fulfillment of national health objectives. Investments in local production enable the formation of efficient and flexible supply chains leading to timely delivery, minimized reliance on imports, and enhanced affordability of modern blood and cell collection systems. In a recent example from November 2024, Terumo Blood and Cell Technologies, an American medical technology company, teamed up with Terumo Medical Products (Hangzhou) Co., Ltd., a medical technology subsidiary based in China, to initiate production locally in Hangzhou, China. The collaboration’s focus was to locally manufacture crucial leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both extensively utilized in China for therapeutic apheresis, stem cell collection, and blood component separation.
Who Are The Dominant Players In The Leukapheresis Device Market Today?
Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, Medica S.p.A.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Leukapheresis Device Market?
North America was the largest region in the leukapheresis device market in 2024. The regions covered in the leukapheresis device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp
Browse Through More Reports Similar to the Global Leukapheresis Device Market 2025, By The Business Research Company
Electrical Stimulation Devices Global Market Report 2025
Cell Therapy Technologies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Leukemia Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
